Literature DB >> 26902725

Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii.

Joseph G Graham1, Caylin G Winchell1, Richard C Kurten2,3, Daniel E Voth4.   

Abstract

Coxiella burnetii is an intracellular bacterial pathogen that causes human Q fever, an acute debilitating flu-like illness that can also present as chronic endocarditis. Disease typically occurs following inhalation of contaminated aerosols, resulting in an initial pulmonary infection. In human cells, C. burnetii generates a replication niche termed the parasitophorous vacuole (PV) by directing fusion with autophagosomes and lysosomes. C. burnetii requires this lysosomal environment for replication and uses a Dot/Icm type IV secretion system to generate the large PV. However, we do not understand how C. burnetii evades the intracellular immune surveillance that triggers an inflammatory response. We recently characterized human alveolar macrophage (hAM) infection in vitro and found that avirulent C. burnetii triggers sustained interleukin-1β (IL-1β) production. Here, we evaluated infection of ex vivo human lung tissue, defining a valuable approach for characterizing C. burnetii interactions with a human host. Within whole lung tissue, C. burnetii preferentially replicated in hAMs. Additionally, IL-1β production correlated with formation of an apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC)-dependent inflammasome in response to infection. We also assessed potential activation of a human-specific noncanonical inflammasome and found that caspase-4 and caspase-5 are processed during infection. Interestingly, although inflammasome activation is closely linked to pyroptosis, lytic cell death did not occur following C. burnetii-triggered inflammasome activation, indicating an atypical response after intracellular detection. Together, these studies provide a novel platform for studying the human innate immune response to C. burnetii.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26902725      PMCID: PMC4862715          DOI: 10.1128/IAI.00012-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  CULTIVATION OF RICKETTSIAE OF THE ROCKY MOUNTAIN SPOTTED FEVER, TYPHUS AND Q FEVER GROUPS IN THE EMBRYONIC TISSUES OF DEVELOPING CHICKS.

Authors:  H R Cox
Journal:  Science       Date:  1941-10-31       Impact factor: 47.728

3.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

4.  Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens.

Authors:  Leigh A Knodler; Shauna M Crowley; Ho Pan Sham; Hyungjun Yang; Marie Wrande; Caixia Ma; Robert K Ernst; Olivia Steele-Mortimer; Jean Celli; Bruce A Vallance
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

5.  Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model.

Authors:  A Moos; T Hackstadt
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule.

Authors:  Jeffrey G Shannon; Dale Howe; Robert A Heinzen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

Review 7.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

8.  Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection.

Authors:  Bärbel Raupach; Soo-Kyung Peuschel; Denise M Monack; Arturo Zychlinsky
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 9.  Coxiella type IV secretion and cellular microbiology.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Curr Opin Microbiol       Date:  2009-01-12       Impact factor: 7.934

10.  Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.

Authors:  Paul A Beare; Stacey D Gilk; Charles L Larson; Joshua Hill; Christopher M Stead; Anders Omsland; Diane C Cockrell; Dale Howe; Daniel E Voth; Robert A Heinzen
Journal:  mBio       Date:  2011-09-01       Impact factor: 7.867

View more
  13 in total

1.  Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent Coxiella burnetii.

Authors:  Amanda L Dragan; Richard C Kurten; Daniel E Voth
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

2.  Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.

Authors:  Laura Schoenlaub; Rama Cherla; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 3.  Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions.

Authors:  Charles L Larson; Eric Martinez; Paul A Beare; Brendan Jeffrey; Robert A Heinzen; Matteo Bonazzi
Journal:  Future Microbiol       Date:  2016-07-15       Impact factor: 3.165

Review 4.  Coxiella burnetii: international pathogen of mystery.

Authors:  Amanda L Dragan; Daniel E Voth
Journal:  Microbes Infect       Date:  2019-09-28       Impact factor: 2.700

5.  Infection of Primary Human Alveolar Macrophages Alters Staphylococcus aureus Toxin Production and Activity.

Authors:  Katelynn R Brann; Marissa S Fullerton; Frances I Onyilagha; Andrew A Prince; Richard C Kurten; Joseph S Rom; Jon S Blevins; Mark S Smeltzer; Daniel E Voth
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

6.  Coxiella burnetii Plasmid Effector B Promotes LC3-II Accumulation and Contributes To Bacterial Virulence in a SCID Mouse Model.

Authors:  Mengjiao Fu; Jianing Zhang; Mingliang Zhao; Shan Zhang; Lupeng Dai; Xuan Ouyang; Yonghui Yu; Bohai Wen; Dongsheng Zhou; Yansong Sun; Jun Jiao; Xiaolu Xiong
Journal:  Infect Immun       Date:  2022-05-19       Impact factor: 3.609

7.  To die or not to die: Programmed cell death responses and their interactions with Coxiella burnetii infection.

Authors:  Chelsea A Osbron; Alan G Goodman
Journal:  Mol Microbiol       Date:  2022-02-02       Impact factor: 3.979

8.  Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.

Authors:  Talita D Fernandes; Larissa D Cunha; Juliana M Ribeiro; Liliana M Massis; Djalma S Lima-Junior; Hayley J Newton; Dario S Zamboni
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 9.  Precision-cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases.

Authors:  Flávia Viana; Cecilia M O'Kane; Gunnar N Schroeder
Journal:  Mol Microbiol       Date:  2021-10-31       Impact factor: 3.979

10.  Coxiella burnetii Employs the Dot/Icm Type IV Secretion System to Modulate Host NF-κB/RelA Activation.

Authors:  Saugata Mahapatra; Brandi Gallaher; Sydni Caet Smith; Joseph G Graham; Daniel E Voth; Edward I Shaw
Journal:  Front Cell Infect Microbiol       Date:  2016-12-19       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.